e-learning
resources
Stockholm 2007
Monday 17.09.2007
Cystic fibrosis lung disease: from diagnosis to end-stage
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The diagnostic value of
pseudomonas aeruginosa
serology as markers of early respiratory infection in young children with cystic fibrosis
T. Douglas, C. Goh, K. Winfield, S. Stick, P. Sly, S. Brennan (Perth, Australia)
Source:
Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage
Session:
Cystic fibrosis lung disease: from diagnosis to end-stage
Session type:
Oral Presentation
Number:
2661
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
T. Douglas, C. Goh, K. Winfield, S. Stick, P. Sly, S. Brennan (Perth, Australia). The diagnostic value of
pseudomonas aeruginosa
serology as markers of early respiratory infection in young children with cystic fibrosis. Eur Respir J 2007; 30: Suppl. 51, 2661
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Azithromycin in chronic respiratory infections with
pseudomonas aeruginosa
in patients without cystic fibrosis
Source: Annual Congress 2008 - Mechanisms of respiratory infections: interaction between the pathogen and the host
Year: 2008
Pseudomonas aeruginosa infections
Source: Respipedia Article
Year: 2018
Acquisition and eradication of P. aeruginosa in young children with cystic fibrosis
Source: Eur Respir J 2009; 33: 305-311
Year: 2009
Diagnostic value of serological tests against
Pseudomonas aeruginosa
in cystic fibrosis patients
Source: Annual Congress 2010 - New aspects of cystic fibrosis
Year: 2010
Evaluating the Leeds criteria for Pseudomonas aeruginosa infection in a cystic fibrosis centre
Source: Eur Respir J 2006; 27: 937-943
Year: 2006
The efficacy of early eradication therapy in prevention of chronic
pseudomonas aeruginosa
infection in cystic fibrosis
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006
Epidemiological-molecular study of colonization by pseudomonas aeruginosa in cystic fibrosis patients
Source: Eur Respir J 2002; 20: Suppl. 38, 379s
Year: 2002
DNA fingerprinting of pseudomonas aeruginosa in cystic fibrosis patients: risk assessment of cross-infection in a CF centre
Source: Eur Respir J 2002; 20: Suppl. 38, 208s
Year: 2002
Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections
Source: Eur Respir J 2012; 40: 227-238
Year: 2012
MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis
Source: ERJ Open Res 2016
Year: 2016
Early re-colonization with
pseudomonas aeruginosa
(PA) after treatment: a possible risk factor for development of chronic infection in cystic fibrosis (CF) patients
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Pseudomonas aeruginosa
in patients with cystic fibrosis - a comparison of early eradication and conventional therapy
Source: Eur Respir J 2004; 24: Suppl. 48, 385s
Year: 2004
Viral infections trigger exacerbations of cystic fibrosis in adults and children
Source: Eur Respir J 2012; 40: 510-512
Year: 2012
Audit on the MRSA infection in adults with cystic fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 640s
Year: 2004
Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018
Does sputum induction improve
Pseudomonas aeruginosa
detection in cystic fibrosis?
Source: Eur Respir J 2003; 22: Suppl. 45, 231s
Year: 2003
Bacterial infection and lung function in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 615s
Year: 2005
Sputum versus bronchoscopy for diagnosis of Pseudomonas aeruginosa biofilms in cystic fibrosis
Source: Eur Respir J 2004; 24 : 631-637
Year: 2004
Achromobacter (A.) xylosoxidans
in cystic fibrosis: prevalence and clinical relevance
Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle
Year: 2005
The identification of bacterial strains in specimens of adult cystic fibrosis patients
Source: Eur Respir J 2004; 24: Suppl. 48, 49s
Year: 2004
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept